MARINOL Side Effects

6839117-0 | Mental Status Changes
on Feb 26, 2010 Male patient from UNITED STATES , 65 years of age, weighting 165.3 lb, was diagnosed with decreased appetite, non-small cell lung cancer and was treated with Marinol (View Usage). Patient experienced the following unwanted or unexpected effects: mental status changes. Marinol dosage: 5 Milligram(s)/kilogram Qd Oral Daily Dose: 5 Milligram(s)/kilogram. During the same period patient was treated with TARCEVA (150 Milligram(s) Qd Oral Daily Dose: 150 Milligram(s)) (View Tarceva Review and Tarceva Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), EFFEXOR (View Effexor Review and Effexor Label ), MEGACE (View Megace Review and Megace Label ), KYTRIL (View Kytril Review and Kytril Label ). Patient was hospitalized.

6709562-2 | Capsule Issue, Foreign Body, Product Shape Issue
Patient was taking Marinol (View Usage). Patient had the following side effects: capsule issue, foreign body, product shape issue on May 03, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 130.0 lb, was diagnosed with hiv wasting syndrome (What is hiv wasting syndrome?) and. Marinol dosage: 5mg Bid Po.

6595921-8 | Cardiomyopathy, Confusional State, Decreased Appetite, Mental Status Changes, Weight Decreased, White Blood Cell Count Increased
Adverse event was reported on Feb 19, 2010 by a Female patient taking Marinol (View Usage) (Dosage: 5 Mg Bid Po) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 58 years of age, After Marinol was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), confusional state, decreased appetite, mental status changes, weight decreased, white blood cell count increased. During the same period patient was treated with ABRAXANE (151 Mg Weekly Iv) (View Abraxane Review and Abraxane Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), GEMZAR (View Gemzar Review and Gemzar Label ), ABROXANE (View Abroxane Review and Abroxane Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), PROCRIT (View Procrit Review and Procrit Label ), LEUKINE (View Leukine Review and Leukine Label ). Patient was hospitalized.

6409387-1 | Lip Swelling
on Oct 19, 2009 Female patient from UNITED STATES , 87 years of age, weighting 121.3 lb, was diagnosed with decreased appetite and was treated with Marinol (View Usage). Patient experienced the following unwanted or unexpected effects: lip swelling. Marinol dosage: Marinol Oral. During the same period patient was treated with KDUR (View Kdur Review and Kdur Label ), ZOCOR (View Zocor Review and Zocor Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), BUMEX (View Bumex Review and Bumex Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), VICODIN (View Vicodin Review and Vicodin Label ), MITRAZOL (View Mitrazol Review and Mitrazol Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ).


5670489-9 | Dyspnoea, Headache, Nausea, Post Procedural Complication
on Mar 12, 2008 Male patient from CANADA , weighting 130.1 lb, was diagnosed with sensory disturbance and was treated with Marinol (View Usage). Patient had the following side effects: dyspnoea, headache (What is headache?), nausea (What is nausea?), post procedural complication. Marinol dosage: Daily Dose: 2.5 Milligram(s). Patient was hospitalized.

5659569-1 | Dyspnoea, Headache, Nausea, Post Procedural Complication
Patient was taking Marinol (View Usage). After Marinol was administered, patient had the following side effects: dyspnoea, headache (What is headache?), nausea (What is nausea?), post procedural complication on Mar 04, 2008 from CANADA Additional patient health information: Male patient , weighting 130.1 lb, was diagnosed with sensory disturbance and. Marinol dosage: Daily Dose: 2.5 Milligram(s). Patient was hospitalized.

5642955-3 | Bladder Cancer, Urinary Bladder Haemorrhage
Adverse event was reported on Feb 19, 2008 by a Male patient taking Marinol (View Usage) (Dosage: Daily Dose: 1-4 Capsules) was diagnosed with back pain (What is back pain?) and. Location: UNITED STATES , weighting 185.2 lb, Patient experienced the following unwanted or unexpected effects: bladder cancer (What is bladder cancer?), urinary bladder haemorrhage. During the same period patient was treated with ALEVE (View Aleve Review and Aleve Label ).

5624464-0 | Dyspnoea, Headache, Nausea, Post Procedural Complication
on Feb 06, 2008 Male patient from CANADA , weighting 130.1 lb, was diagnosed with sensory disturbance and was treated with Marinol (View Usage). Patient had the following side effects: dyspnoea, headache (What is headache?), nausea (What is nausea?), post procedural complication. Marinol dosage: Daily Dose: 2.5 Milligram(s). Patient was hospitalized.

5556857-4 | Convulsion
on Dec 12, 2007 Male patient from UNITED STATES , 77 years of age, weighting 216.1 lb, was diagnosed with decreased appetite and was treated with Marinol (View Usage). After Marinol was administered, patient had the following side effects: convulsion. Marinol dosage: 10 Mg Bid Po. Patient was hospitalized.

5470864-1 | Aggression, Anger, Depression
Patient was taking Marinol (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, anger, depression (What is depression?) on Sep 20, 2007 from UNITED STATES Additional patient health information: Male patient , 32 years of age, was diagnosed with ill-defined disorder and. Marinol dosage: . During the same period patient was treated with KADIAN (View Kadian Review and Kadian Label ), VICOPROFEN (View Vicoprofen Review and Vicoprofen Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), XANAX (View Xanax Review and Xanax Label ).

5358563-8 | Visual Field Defect
Adverse event was reported on Jun 13, 2007 by a Female patient taking Marinol (View Usage) (Dosage: Daily Dose: 30 Milligram(s)) was diagnosed with ill-defined disorder, porphyria acute and. Location: UNITED STATES , 27 years of age, weighting 116.8 lb, Patient had the following side effects: visual field defect. During the same period patient was treated with MARIJUANA (Daily Dose: As Needed) (View Marijuana Review and Marijuana Label ).

5342141-0 | Visual Field Defect
on May 30, 2007 Female patient from UNITED STATES , 27 years of age, weighting 116.8 lb, was diagnosed with ill-defined disorder, porphyria acute and was treated with Marinol (View Usage). After Marinol was administered, patient had the following side effects: visual field defect. Marinol dosage: Daily Dose: 30 Milligram(s). During the same period patient was treated with MARIJUANA (Daily Dose: As Needed) (View Marijuana Review and Marijuana Label ).

5262201-2 |
on Mar 05, 2007 Male patient from UNITED STATES , 44 years of age, was diagnosed with hiv wasting syndrome (What is hiv wasting syndrome?) and was treated with Marinol (View Usage). . Marinol dosage: .

5166550-8 | Cervical Vertebral Fracture, Fall, Intentional Overdose, Loss Of Consciousness, Respiratory Arrest
Patient was taking Marinol (View Usage). Patient had the following side effects: cervical vertebral fracture, fall (What is fall?), intentional overdose, loss of consciousness, respiratory arrest on Dec 05, 2006 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with depression (What is depression?) and. Marinol dosage: .

5152291-X | Fall, Orthostatic Hypotension, Tremor
Adverse event was reported on Sep 21, 2006 by a Male patient taking Marinol (View Usage) (Dosage: Daily Dose: 2.5 Milligram(s)) was diagnosed with decreased appetite, ill-defined disorder and. Location: UNITED STATES , weighting 176.4 lb, After Marinol was administered, patient had the following side effects: fall (What is fall?), orthostatic hypotension, tremor. During the same period patient was treated with TOPROL XL (Daily Dose: 50 Milligram(s)) (View Toprol-xl Review and Toprol-xl Label ), ASPIRIN (Daily Dose: 325 Milligram(s)) (View Aspirin Review and Aspirin Label ), ZOCOR (Daily Dose: 20 Milligram(s)) (View Zocor Review and Zocor Label ), METFORMIN (Daily Dose: 500 Milligram(s)) (View Metformin Review and Metformin Label ), NPH INSULIN (Daily Dose: 40 International Unit(s)) (View Nph Insulin Review and Nph Insulin Label ), CHLORPROMAZINE (Daily Dose: 25 Milligrams As Needed) (View Chlorpromazine Review and Chlorpromazine Label ). Patient was hospitalized.

5125973-3 | Postoperative Wound Infection, Staphylococcal Infection
on Oct 10, 2006 Male patient from UNITED STATES , 27 years of age, was diagnosed with increased appetite, nausea (What is nausea?) and was treated with Marinol (View Usage). Patient experienced the following unwanted or unexpected effects: postoperative wound infection, staphylococcal infection (What is staphylococcal infection?). Marinol dosage: 2.5mg Po Qd. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5083198-4 | Chest Pain, Dizziness, Multiple Sclerosis
on Nov 21, 2003 Male patient from UNITED KINGDOM , 57 years of age, weighting 187.4 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and was treated with Marinol (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dizziness (What is dizziness?), multiple sclerosis (What is multiple sclerosis?). Marinol dosage: 1 Dosage Form Bid Oral Daily Dose: 2.5 To 20 Mg. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), COPROXAMOL (View Coproxamol Review and Coproxamol Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), NAFTIDROFURYL OALATE (View Naftidrofuryl Oalate Review and Naftidrofuryl Oalate Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

5083197-2 | Urinary Tract Infection
Patient was taking Marinol (View Usage). After Marinol was administered, patient had the following side effects: urinary tract infection (What is urinary tract infection?) on Nov 21, 2003 from UNITED KINGDOM Additional patient health information: Female patient , 54 years of age, weighting 260.1 lb, was diagnosed with muscle spasticity, multiple sclerosis (What is multiple sclerosis?) and. Marinol dosage: Daily Oral: 2.5 To 25 Mg., 15 Mg Daily Oral. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), PROPIVERINE (View Propiverine Review and Propiverine Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), CEFA;EXON (CEFALEXIN) (View Cefa;exon (cefalexin) Review and Cefa;exon (cefalexin) Label ). Patient was hospitalized.

5083196-0 | Cellulitis, Diarrhoea, Vomiting
Adverse event was reported on Nov 21, 2003 by a Female patient taking Marinol (View Usage) (Dosage: Daily Oral: 5-15 Mg, Titration) was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and. Location: UNITED KINGDOM , 48 years of age, Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), diarrhoea, vomiting. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), TOLTERODINE TARTRATE (View Tolterodine Tartrate Review and Tolterodine Tartrate Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

5083195-9 | Multiple Sclerosis
on Nov 21, 2003 Female patient from UNITED KINGDOM , 58 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and was treated with Marinol (View Usage). Patient had the following side effects: multiple sclerosis (What is multiple sclerosis?). Marinol dosage: 1 Dosage Form Qd Oral Daily Dose: 5 To 20 Mg Daily. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), PROPANTHELINE (View Propantheline Review and Propantheline Label ). Patient was hospitalized.

5083194-7 | Multiple Sclerosis Relapse
on Nov 21, 2003 Female patient from UNITED KINGDOM , 33 years of age, was diagnosed with muscle spasticity, multiple sclerosis (What is multiple sclerosis?) and was treated with Marinol (View Usage). After Marinol was administered, patient had the following side effects: multiple sclerosis relapse. Marinol dosage: 1 Dosage Form Bid Oral Daily Dose: Titration Dose From 2.5 Mg To 12.5 Mg. During the same period patient was treated with INJECTED CONTRACEPTION (View Injected Contraception Review and Injected Contraception Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

5083193-5 | Muscle Spasms, Musculoskeletal Stiffness, Urinary Tract Infection
Patient was taking Marinol (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms, musculoskeletal stiffness, urinary tract infection (What is urinary tract infection?) on Nov 21, 2003 from UNITED KINGDOM Additional patient health information: Female patient , 61 years of age, weighting 141.1 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and. Marinol dosage: 1 Dosage Form Bid Oral Daily Dose: From 2.5 Mg To 15 Mg. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), EVENING PRIMROSE OIL (View Evening Primrose Oil Review and Evening Primrose Oil Label ). Patient was hospitalized.

5083192-3 | Urinary Tract Infection
Adverse event was reported on Nov 21, 2003 by a Male patient taking Marinol (View Usage) (Dosage: ) was diagnosed with muscle spasticity, multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED KINGDOM , 48 years of age, Patient had the following side effects: urinary tract infection (What is urinary tract infection?). During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), CO AMILFRUSE (View Co-amilfruse Review and Co-amilfruse Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

5083191-1 | Catheter Related Complication, Pleural Effusion, Transient Ischaemic Attack
on Nov 21, 2003 Male patient from UNITED KINGDOM , 52 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and was treated with Marinol (View Usage). After Marinol was administered, patient had the following side effects: catheter related complication, pleural effusion, transient ischaemic attack. Marinol dosage: Daily Oral: 2.5 Mg-20 Mg Titration. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), GAMOLENIC ACID (View Gamolenic Acid Review and Gamolenic Acid Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ). Patient was hospitalized.

5083189-3 | Pleural Effusion
on Nov 21, 2003 Female patient from UNITED KINGDOM , 57 years of age, weighting 153.4 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and was treated with Marinol (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion. Marinol dosage: . During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), BECONASE (View Beconase Review and Beconase Label ), CLIMESSE (View Climesse Review and Climesse Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ).

5083159-5 | Fall, Head Injury, Multiple Sclerosis
Patient was taking Marinol (View Usage). Patient had the following side effects: fall (What is fall?), head injury, multiple sclerosis (What is multiple sclerosis?) on Nov 21, 2003 from UNITED KINGDOM Additional patient health information: Male patient , 52 years of age, weighting 169.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and. Marinol dosage: Oral Daily Dose: Titration Dose From 2.5 Mg To 20 Mg. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), EVENING PRIMROSE OIL (EVENING PRIMROSE OIL) (View Evening Primrose Oil (evening Primrose Oil) Review and Evening Primrose Oil (evening Primrose Oil) Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MEBEVERINE (MEBEVERINE) (View Mebeverine (mebeverine) Review and Mebeverine (mebeverine) Label ). Patient was hospitalized.

5083158-3 | Fall, Multiple Sclerosis Relapse, Musculoskeletal Stiffness, Urinary Tract Infection
Adverse event was reported on Nov 21, 2003 by a Male patient taking Marinol (View Usage) (Dosage: Bid Oral Daily) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED KINGDOM , 35 years of age, After Marinol was administered, patient had the following side effects: fall (What is fall?), multiple sclerosis relapse, musculoskeletal stiffness, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ), SELENIUM AND ZINC (SELENIUM AND ZINC) (View Selenium And Zinc (selenium And Zinc) Review and Selenium And Zinc (selenium And Zinc) Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), VITAMIN B COMPLEX (VITAMIN B COMPLEX) (View Vitamin B Complex (vitamin B Complex) Review and Vitamin B Complex (vitamin B Complex) Label ), VITAMIN C (VITAMIN C) (View Vitamin C (vitamin C) Review and Vitamin C (vitamin C) Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), ZINC (ZINC) (View Zinc (zinc) Review and Zinc (zinc) Label ). Patient was hospitalized.

5083157-1 | Groin Abscess
on Nov 21, 2003 Female patient from UNITED KINGDOM , 34 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and was treated with Marinol (View Usage). Patient experienced the following unwanted or unexpected effects: groin abscess. Marinol dosage: Oral. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), DOTHIEPIN (DOTHIEPIN) (View Dothiepin (dothiepin) Review and Dothiepin (dothiepin) Label ), OXYBUTININ (OXYBUTININ) (View Oxybutinin (oxybutinin) Review and Oxybutinin (oxybutinin) Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), TIZANIDINE HCL (View Tizanidine Hcl Review and Tizanidine Hcl Label ). Patient was hospitalized.

5083156-X | Multiple Sclerosis Relapse
on Nov 21, 2003 Female patient from UNITED KINGDOM , 48 years of age, weighting 160.9 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and was treated with Marinol (View Usage). Patient had the following side effects: multiple sclerosis relapse. Marinol dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5083155-8 | Diarrhoea, Haematuria, Urinary Tract Infection, Vomiting
Patient was taking Marinol (View Usage). After Marinol was administered, patient had the following side effects: diarrhoea, haematuria, urinary tract infection (What is urinary tract infection?), vomiting on Nov 21, 2003 from UNITED KINGDOM Additional patient health information: Male patient , 50 years of age, weighting 196.2 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and. Marinol dosage: See Image. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), EVENING PRIMROSE OIL (EVENING PRIMROSE OIL) (View Evening Primrose Oil (evening Primrose Oil) Review and Evening Primrose Oil (evening Primrose Oil) Label ), MOVICOL (MOVICOL) (View Movicol (movicol) Review and Movicol (movicol) Label ). Patient was hospitalized.

5083154-6 | Pneumonia
Adverse event was reported on Nov 21, 2003 by a Female patient taking Marinol (View Usage) (Dosage: 1 Dosage Form Qd Oral Daily Dose: 1 Dosage Form) was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and. Location: UNITED KINGDOM , 55 years of age, weighting 81.57 lb, Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ). Patient was hospitalized.

5083153-4 | Asthenia, Nephrolithiasis, Pneumonia, Pyrexia
on Nov 21, 2003 Male patient from UNITED KINGDOM , 51 years of age, weighting 127.9 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), muscle spasticity and was treated with Marinol (View Usage). Patient had the following side effects: asthenia, nephrolithiasis, pneumonia (What is pneumonia?), pyrexia. Marinol dosage: 1 Dosage Form Bid Oral Daily Dose: 5 To 15 Mg. During the same period patient was treated with DANTROLENE SODIUM (View Dantrolene Sodium Review and Dantrolene Sodium Label ), GARLIC CAPSULES (GARLIC CAPSULES) (View Garlic Capsules (garlic Capsules) Review and Garlic Capsules (garlic Capsules) Label ). Patient was hospitalized.

5083152-2 | Respiratory Tract Infection, Urinary Tract Infection
on Nov 21, 2003 Female patient from UNITED STATES , 63 years of age, weighting 141.1 lb, was diagnosed with muscle spasticity, multiple sclerosis (What is multiple sclerosis?) and was treated with Marinol (View Usage). After Marinol was administered, patient had the following side effects: respiratory tract infection, urinary tract infection (What is urinary tract infection?). Marinol dosage: 1 Dosage Form Qd Oral Daily Dose: 1 Dosage Form. During the same period patient was treated with DESMOPRESSIN ACETATE (View Desmopressin Acetate Review and Desmopressin Acetate Label ), OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ). Patient was hospitalized.

5083151-0 | Arthralgia, Arthritis, Muscle Spasticity, Muscle Tightness
Patient was taking Marinol (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, arthritis (What is arthritis?), muscle spasticity, muscle tightness on Nov 21, 2003 from UNITED KINGDOM Additional patient health information: Male patient , 51 years of age, was diagnosed with muscle spasticity, multiple sclerosis (What is multiple sclerosis?) and. Marinol dosage: 1 Dosage Form Bid Oral Daily Dose: 1 Dosage Form. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), DICLOFENAC (DICLOFENAC) (View Diclofenac (diclofenac) Review and Diclofenac (diclofenac) Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

5083150-9 | Affect Lability, Asthenia, Urinary Tract Infection
Adverse event was reported on Nov 21, 2003 by a Female patient taking Marinol (View Usage) (Dosage: ) was diagnosed with muscle spasticity, multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED KINGDOM , 48 years of age, weighting 163.1 lb, Patient had the following side effects: affect lability, asthenia, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

4991456-4 | Convulsion, Disorientation, Dyskinesia, Foaming At Mouth, Hallucination, Heart Rate Increased, Muscle Twitching, Tremor
on May 01, 2006 Female patient from UNITED STATES , 40 years of age, weighting 280.0 lb, was diagnosed with nausea (What is nausea?) and was treated with Marinol (View Usage). After Marinol was administered, patient had the following side effects: convulsion, disorientation, dyskinesia, foaming at mouth, hallucination, heart rate increased, muscle twitching, tremor. Marinol dosage: One 5 Mg Tablet 3x Day Before Meal Po. Patient was hospitalized.

4987843-0 | Anxiety, Arteriospasm Coronary, Chest Discomfort, Dizziness, Dyskinesia, Electrocardiogram Change, Muscle Twitching, Myocardial Ischaemia, Palpitations
on Apr 27, 2006 Female patient from UNITED STATES , weighting 151.5 lb, was treated with Marinol (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), arteriospasm coronary, chest discomfort, dizziness (What is dizziness?), dyskinesia, electrocardiogram change, muscle twitching, myocardial ischaemia, palpitations. Marinol dosage: 10 Mg Single Po. During the same period patient was treated with MARVELON (View Marvelon Review and Marvelon Label ).

4987825-9 | Abdominal Distension, Anxiety, Aphasia, Cogwheel Rigidity, Confusional State, Dizziness, Dyskinesia, Dyspnoea, Extrapyramidal Disorder
Patient was taking Marinol (View Usage). Patient had the following side effects: abdominal distension, anxiety (What is anxiety?), aphasia (What is aphasia?), cogwheel rigidity, confusional state, dizziness (What is dizziness?), dyskinesia, dyspnoea, extrapyramidal disorder on Apr 27, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 190.0 lb, . Marinol dosage: 10 Mg Single Po.

4975498-0 | Parosmia
Adverse event was reported on Apr 17, 2006 by a Male patient taking Marinol (View Usage) (Dosage: 2.5 Mg, 1 Cup Po Tid 5 Cups Po Qhs) . Location: UNITED STATES , 53 years of age, weighting 178.2 lb, After Marinol was administered, patient had the following side effects: parosmia.

4829898-X | Back Pain, Pain In Extremity
on Sep 28, 2005 Female patient from UNITED STATES , 34 years of age, was diagnosed with pain (What is pain?) and was treated with Marinol (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), pain in extremity. Marinol dosage: Daily Dose: 20 Milligram(s). During the same period patient was treated with OPIOIDS (View Opioids Review and Opioids Label ). Patient was hospitalized.

4792389-9 | Pain
on Sep 28, 2005 Female patient from UNITED STATES , 34 years of age, was diagnosed with pain (What is pain?) and was treated with Marinol (View Usage). Patient had the following side effects: pain (What is pain?). Marinol dosage: Daily Dose: 20 Milligram(s). During the same period patient was treated with OPIOIDS (View Opioids Review and Opioids Label ). Patient was hospitalized.